×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Windlas Biotech Limited | 2153.29 | 176.64 | 2100.9 | 8.34 | 2,123 | 32.6 |
| DR.AGARWALS EYE HOSPITAL LTD. | NA | NA | NA | NA | 2120 | 36.7 |
| HESTER BIOSCIENCES LTD. | 644.36 | 78.38 | 634.9 | 9.21 | 1811 | 48.2 |
Windlas Biotech Limited, with Security Code 543329, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 132.7 | 119.7 | 140.7 | 144.8 | 152.7 | 162.2 | 171.3 | 175.2 | 187.0 | 195.0 |
| Expenses | 116.7 | 105.8 | 124.3 | 127.6 | 134.0 | 141.9 | 149.4 | 154.3 | 164.0 | 170.4 |
| Operating Profit | 16.0 | 13.9 | 16.4 | 17.1 | 18.7 | 20.3 | 21.9 | 20.9 | 23.0 | 24.6 |
| OPM % | 12.09% | 11.65% | 11.69% | 11.84% | 12.24% | 12.54% | 12.81% | 11.92% | 12.33% | 12.63% |
| Other Income | 2.6 | 2.2 | 2.3 | 2.6 | 3.2 | 3.2 | 4.4 | 4.1 | 4.8 | 3.7 |
| Interest | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 1.1 | 1.5 |
| Depreciation | 2.9 | 3.1 | 3.6 | 3.2 | 3.3 | 3.4 | 3.5 | 6.2 | 6.5 | 6.9 |
| Profit before tax | 15.6 | 12.8 | 15.0 | 16.3 | 18.3 | 19.8 | 22.6 | 18.3 | 20.3 | 20.0 |
| Tax % | -22% | -28.3% | -23.9% | -26.2% | -23.4% | -23.8% | 24.9% | 26.4% | 22.8% | -23.8% |
| Net Profit | 12.2 | 9.2 | 11.4 | 12.1 | 14.0 | 15.1 | 16.9 | 13.5 | 15.7 | 15.2 |
| EPS in Rs | 5.59 | 4.24 | 5.37 | 5.79 | 6.75 | 7.26 | 8.12 | 6.44 | 7.43 | 7.21 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 140.7 | 144.8 | 152.7 | 162.2 | 171.3 | 175.2 | 187.0 | 195.0 | 202.7 | 210.1 |
| Expenses | 124.3 | 127.6 | 134.0 | 141.9 | 149.3 | 154.3 | 164.0 | 170.4 | 177.1 | 183.6 |
| Operating Profit | 16.4 | 17.1 | 18.7 | 20.3 | 22.0 | 20.9 | 23.0 | 24.6 | 25.6 | 26.5 |
| OPM % | 11.68% | 11.84% | 12.24% | 12.54% | 12.85% | 11.92% | 12.33% | 12.63% | 12.61% | 12.63% |
| Other Income | 2.3 | 2.6 | 3.2 | 3.2 | 4.4 | 4.1 | 4.8 | 4.1 | 4.9 | 5.2 |
| Interest | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 1.1 | 1.5 | 1.3 | 1.1 |
| Depreciation | 3.6 | 3.2 | 3.3 | 3.4 | 3.5 | 6.2 | 6.5 | 6.9 | 8.3 | 7.4 |
| Profit before tax | 15.0 | 16.3 | 18.3 | 19.8 | 22.6 | 18.3 | 20.3 | 20.3 | 20.8 | 23.3 |
| Tax % | -23.9% | -26.2% | -23.4% | -23.8% | -24.9% | -26.4% | -22.8% | 23.4% | -21.6% | 24% |
| Net Profit | 11.4 | 12.1 | 14.0 | 15.1 | 17.0 | 13.5 | 15.7 | 15.6 | 16.3 | 17.7 |
| EPS in Rs | 5.37 | 5.79 | 6.75 | 7.26 | 8.14 | 6.44 | 7.43 | 7.38 | 0 | 8.34 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 63% |
| 1 Year: | 56% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 30% |
| 3 Years: | 17% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 63% |
| 1 Year: | 56% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|